Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
Multiple randomized, placebo-controlled and real-world studies have shown biologics to have high levels of efficacy, tolerability and safety for atopic dermatitis since approval. Yet, there are still patients who either don’t respond or lose response over time. Herein, we provide a framework on how to approach these patients including how to optimize add-on therapy to dupilumab and when to consider switching to an alternative therapy. A Q&A session is included in this discussion with Dr. James Song and guest speaker Dr. Andrew Blauvelt.
Supported By
Faculty
Dr. Song is the director of clinical research at Frontier Dermatology Partners. He is also a clinical instructor at the University of Washington and Silver Falls Dermatology. He specializes in inflammatory skin diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa. Dr. Song is a regular contributor to the dermatology literature and speaks across the country as a key opinion leader.
Related Courses
Atopic Dermatitis
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
Atopic Dermatitis
Atopic Dermatitis Pathogenesis and the Biologics that Target This Cytokine
Atopic Dermatitis
Therapeutic Alignment – All Practitioners Come Together
Atopic Dermatitis
Managing a Patient with Chronic Severe Atopic Dermatitis
